This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Joshi K, Lin J, Lingohr-Smith M, Fu DJ, Muser E. Treatment patterns and antipsychotic medication adherence among commercially insured patients with schizoaffective disorder in the United States. Journal of clinical psychopharmacology. 2016 Oct;36(5):429.JoshiKLinJLingohr-SmithMFuDJMuserETreatment patterns and antipsychotic medication adherence among commercially insured patients with schizoaffective disorder in the United States201636542910.1097/JCP.0000000000000549501726927525965Search in Google Scholar
Jiang Y, McCombs JS, Park SH. A retrospective cohort study of acute kidney injury risk associated with antipsychotics. CNS drugs. 2017 Apr 1;31(4):319-26.JiangYMcCombsJSParkSHA retrospective cohort study of acute kidney injury risk associated with antipsychotics2017Apr 13143192610.1007/s40263-017-0421-428290080Search in Google Scholar
Sood L, Owen A, Saini M. Olanzapine-induced rhabdomyolysis. Irish Journal of psychological medicine. 2006 Sep;23(3):114-5.SoodLOwenASainiMOlanzapine-induced rhabdomyolysis2006233114510.1017/S079096670000977030290514Search in Google Scholar
Khan FY. Rhabdomyolysis: a review of the literature. Neth J Med. 2009 Oct 1;67(9):272-83.KhanFYRhabdomyolysis: a review of the literature2009Oct 167927283Search in Google Scholar
Huerta-Alardín AL, Varon J, Marik PE. Bench-to-bedside review: Rhabdomyolysis–an overview for clinicians. Critical care. 2004 Apr 1;9(2):158.Huerta-AlardínALVaronJMarikPE.Bench-to-bedside review: Rhabdomyolysis–an overview for clinicians2004Apr 19215810.1186/cc2978117590915774072Search in Google Scholar
Virupannavar S, Volkov S. An Unusual Presentation of Rhabdomyolysis in a Newly Diagnosed Sjögren’s Syndrome Associated Polymyositis. Archives of rheumatology. 2016 Sep;31(3):281.VirupannavarSVolkovSAn Unusual Presentation of Rhabdomyolysis in a Newly Diagnosed Sjögren’s Syndrome Associated Polymyositis201631328110.5606/ArchRheumatol.2016.5740582785429900949Search in Google Scholar
Savage DC, Forbes M, Pearce GW. Idiopathic rhabdomyolysis. Archives of disease in childhood. 1971 Oct 1;46(249):594-607.SavageDCForbesMPearceGWIdiopathic rhabdomyolysis1971Oct 14624959460710.1136/adc.46.249.59416478324107384Search in Google Scholar
Rodríguez-Quintero JH, Ramos-Pineda A, Salas-Villela R, Gotés-Palazuelos J. Refractory hypercalcemia after idiopathic rhabdomyolysis. Clinical Cases in Mineral & Bone Metabolism. 2018 Sep 1;15(3):358-363.Rodríguez-QuinteroJHRamos-PinedaASalas-VillelaRGotés-PalazuelosJ.Refractory hypercalcemia after idiopathic rhabdomyolysis2018Sep 1153358363Search in Google Scholar
Watson JD, Gifford SM, Clouse WD. Biochemical markers of acute limb ischemia, rhabdomyolysis, and impact on limb salvage. In Seminars in vascular surgery. WB Saunders. 2014 Dec; 27(3-4):176-181)WatsonJDGiffordSMClouseWDBiochemical markers of acute limb ischemia, rhabdomyolysis, and impact on limb salvage2014273-417618110.1053/j.semvascsurg.2015.01.00726073828Search in Google Scholar
Jiang W, Wang X, Zhou S. Rhabdomyolysis induced by antiepileptic drugs: characteristics, treatment and prognosis. Expert opinion on drug safety. 2016 Mar 3;15(3):357-65.JiangWWangXZhouSRhabdomyolysis induced by antiepileptic drugs: characteristics, treatment and prognosis2016Mar 31533576510.1517/14740338.2016.113957226750987Search in Google Scholar
Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. New England Journal of Medicine. 2009 Jul 2;361(1):6272.BoschXPochEGrauJMRhabdomyolysis and acute kidney injury2009Jul 23611627210.1056/NEJMra080132719571284Search in Google Scholar
Cervellin G, Comelli I, Lippi G. Rhabdomyolysis: historical background, clinical, diagnostic and therapeutic features. Clinical chemistry and laboratory medicine. 2010 Jun 1;48(6):749-56.CervellinGComelliILippiGRhabdomyolysis: historical background, clinical, diagnostic and therapeutic features2010Jun 14867495610.1515/CCLM.2010.15120298139Search in Google Scholar
Onofrei SD, Radulescu D, Peride I, Niculae A, Checherita IA. Fibroblast Growth Factor 23 and Cardiovascular Outcome in Acute Kidney Injury. Revista de Chimie. 2019 Apr 1;70(4):126871.OnofreiSDRadulescuDPerideINiculaeAChecheritaIAFibroblast Growth Factor 23 and Cardiovascular Outcome in Acute Kidney Injury2019Apr 170412687110.37358/RC.19.4.7107Search in Google Scholar
Zutt R, Van Der Kooi AJ, Linthorst GE, Wanders R.J., De Visser M. Rhabdomyolysis: review of the literature. Neuromuscular Disorders. 2014 Aug 1;24(8):651-9.ZuttRVanDer Kooi AJLinthorstGEWandersR.J.DeVisser M.Rhabdomyolysis: review of the literature2014Aug 1248651910.1016/j.nmd.2014.05.005Search in Google Scholar
Petejova N, Martinek A. Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review. Critical Care. 2014 Jun;18(3):224.PetejovaNMartinekAAcute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review201418322410.1186/cc13897Search in Google Scholar
Ronco C, Bellomo R, Kellum JA. Critical care nephrology. Philadelphia, USA: Saunders.RoncoCBellomoRKellumJAPhiladelphia, USASaunders10.1007/978-94-011-5482-6Search in Google Scholar
Veenstra J, Smit WM, Krediet RT, Arisz L. Relationship between elevated creatine phosphokinase and the clinical spectrum of rhabdomyolysis. Nephrology Dialysis Transplantation. 1994 Jan 1;9(6):637-41.VeenstraJSmitWMKredietRTAriszLRelationship between elevated creatine phosphokinase and the clinical spectrum of rhabdomyolysis1994Jan 1966374110.1093/ndt/9.6.637Search in Google Scholar
Chatzizisis YS, Misirli G, Hatzitolios AI, Giannoglou GD. The syndrome of rhabdomyolysis: complications and treatment. European journal of internal medicine. 2008 Dec 1;19(8):56874.ChatzizisisYSMisirliGHatzitoliosAIGiannoglouGDThe syndrome of rhabdomyolysis: complications and treatment2008Dec 11985687410.1016/j.ejim.2007.06.037Search in Google Scholar
Pinkston R, Walker LA. Multiorgan system failure caused by valproic acid toxicity. The American journal of emergency medicine. 1997 Sep 1;15(5):504-6.PinkstonRWalkerLAMultiorgan system failure caused by valproic acid toxicity1997Sep 1155504610.1016/S0735-6757(97)90195-9Search in Google Scholar
Altintepe L, Guney I, Tonbul Z, Türk S, Mazi M, Ağca E, Yeksan M. Early and intensive fluid replacement prevents acute renal failure in the crush cases associated with spontaneous collapse of an apartment in Konya. Renal failure. 2007 Jan 1;29(6):737-41.AltintepeLGuneyITonbulZTürkSMaziMAğcaEYeksanMEarly and intensive fluid replacement prevents acute renal failure in the crush cases associated with spontaneous collapse of an apartment in Konya2007Jan 12967374110.1080/0886022070146009517763170Search in Google Scholar
Checheriţă IA, David C, Ciocalteu A, Lascăr I, Budală LA. Oral treatment of metabolic acidosis in hemodialyzed patients and the implications on the hemodynamic status. Rom J Morphol Embryol. 2013;54(3):539-43.ChecheriţăIADavidCCiocalteuALascărIBudalăLA.Oral treatment of metabolic acidosis in hemodialyzed patients and the implications on the hemodynamic status201354353943Search in Google Scholar
Antoon JW, Chakraborti C. Corticosteroids in the treatment of alcohol-induced rhabdomyolysis. Elsevier. In Mayo Clinic Proceedings. 2011 Oct 1;86(10):1005-1007.AntoonJWChakrabortiCCorticosteroids in the treatment of alcohol-induced rhabdomyolysis2011Oct 186101005100710.4065/mcp.2011.0102318403121964178Search in Google Scholar
Waring WS, Wrate J, Bateman DN. Olanzapine overdose is associated with acute muscle toxicity. Human & experimental toxicology. 2006 Dec;25(12):735-40.WaringWSWrateJBatemanDNOlanzapine overdose is associated with acute muscle toxicity200625127354010.1177/096032710607383217286152Search in Google Scholar